STTCOMP TLX TA LONG
Telix Pharma
Market cap - around $1.4B
Oncology biotech with quite an extensive pipeline of products under development in renal, brain, prostate and other cancers. Aiming for FDA approval in around September. Very impressive management. Has been hitting resistance around 4.70/$4.80 but broke through convincingly on Friday. Not so confident about getting 25% in 4 weeks, given the size of the company, but that breakout was impressive.
- Forums
- ASX - Short Term Trading
- Short Term Trading Week Starting: 15 June
STTCOMP TLX TA LONGTelix PharmaMarket cap - around $1.4BOncology...
-
- There are more pages in this discussion • 88 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Featured News
The Watchlist
JBY
JAMES BAY MINERALS LIMITED
Andrew Dornan, Executive Director
Andrew Dornan
Executive Director
SPONSORED BY The Market Online